𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis C virus serotype and response to interferon in chronic hepatitis C

Book ID
118566555
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
142 KB
Volume
21
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Early Hepatitis C virus–RNA responses pr
Early Hepatitis C virus–RNA responses predict interferon treatment outcomes in chronic hepatitis C
✍ William M. Lee; K. Rajender Reddy; Myron J. Tong; Martin Black; Dirk J. van Leeu πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 100 KB πŸ‘ 2 views

In previous studies employing interferons (IFNs) in the treatment of chronic hepatitis C, there have been few reliable predictors of sustained responses. We retrospectively evaluated the predictive value of hepatitis C virus (HCV)-RNA measurements in the first few months during consensus interferon

Virological patterns of hepatitis C viru
Virological patterns of hepatitis C virus in chronic hepatitis C with biochemical sustained response to interferon therapy
✍ M S De Mitri; T Iervese; E Pisi; G Morsica; A Lazzarin πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 154 KB πŸ‘ 2 views

CORRESPONDENCE 1287 tive anions determine the potential for crystal precipi-though the location within the stone is not identified. Thus, their data would seem to confirm our findings tation within bile. Certain disease states predispose and be in conflict with the statement in their letter to supe

Genotypes and titers of hepatitis C viru
Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C
✍ Kunihiko Hino; Shigehiko Sainokami; Kazumi Shimoda; Shiro Iino; Yu Wang; Hiroaki πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 708 KB

## Abstract Interferon induces remission in about 50% of patients with chronic hepatitis C, but it is difficult to predict which patients will respond. Host and viral factors were evaluated for correlation with response to interferon in patients with chronic hepatitis C. Recombinant interferon alph